Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -56.22% is 11% below its 5-year average of -50.73%, around the middle of its 5-year range (-78.74%–-24.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.22% above its 12-month average of -68.74%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -56.22%.
RETURN ON INVESTED CAPITAL (ROIC)
-56.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-68.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-55.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-50.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.22%
CURRENT VS 3Y AVG
-1.21%
CURRENT VS 5Y AVG
-10.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.17%
median of 816 covered companies
CURRENT VS SECTOR MEDIAN
-59.85%
vs the sector median at left
Pliant Therapeutics, Inc.
Market Cap
$63.16M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-68.74%
3Y Avg
-55.55%
5Y Avg
-50.73%
Market Cap
$63.23M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
Market Cap
$63.41M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$63.79M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-4.96%
3Y Avg
-2.45%
5Y Avg
-3.32%
Market Cap
$64.20M
Return on Invested Capital (ROIC)
-139.74%
TTM Avg
-190.33%
3Y Avg
-1114.56%
5Y Avg
-840.48%
Market Cap
$64.49M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$61.44M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
Market Cap
$62.69M
Return on Invested Capital (ROIC)
-129.67%
TTM Avg
-97.71%
3Y Avg
-90.63%
5Y Avg
-82.49%
Market Cap
$60.49M
Return on Invested Capital (ROIC)
-26.13%
TTM Avg
-90.47%
3Y Avg
-104.07%
5Y Avg
-130.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $63.16M | -56.22% | -68.74% | -55.55% | -50.73% |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | -165.22% | -160.52% | -107.11% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | -6.79% | -4.87% | -47.70% | -62.00% |
| InterCure Ltd. (INCR)vs › | $63.79M | -4.72% | -4.96% | -2.45% | -3.32% |
| RenovoRx, Inc. (RNXT)vs › | $64.20M | -139.74% | -190.33% | -1114.56% | -840.48% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.49M | N/A | -86.10% | -83.22% | -74.34% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.44M | -52.40% | -44.92% | -44.92% | -44.02% |
| Fractyl Health, Inc. (GUTS)vs › | $62.69M | -129.67% | -97.71% | -90.63% | -82.49% |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | -26.13% | -90.47% | -104.07% | -130.48% |
| Cingulate Inc. (CING)vs › | $66.27M | -83.74% | -153.15% | -164.21% | -165.99% |
ROIC
-56.2%
ROE
-62.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -56.22% |
| 2026-03-31 | -62.01% |
| 2025-12-31 | -74.87% |
| 2025-09-30 | -71.87% |
| 2025-06-30 | -78.74% |
| 2025-03-31 | -74.20% |
| 2024-12-31 | -62.78% |
| 2024-09-30 | -54.74% |
| 2024-06-30 | -45.88% |
| 2024-03-31 | -39.58% |
| 2023-12-31 | -38.08% |
| 2023-09-30 | -34.01% |
| 2023-06-30 | -29.11% |
| 2023-03-31 | -24.55% |
| 2022-12-31 | -38.93% |
| 2022-09-30 | -32.59% |
| 2022-06-30 | -67.61% |
| 2022-03-31 | -56.90% |
| 2021-12-31 | -47.72% |
| 2021-09-30 | -41.57% |
| 2021-06-30 | -33.29% |
| 2021-03-31 | -28.52% |
| 2020-12-31 | -14.67% |
| 2020-09-30 | 6.50% |
| 2020-06-30 | 7.23% |
| 2020-03-31 | 13.83% |
| 2019-12-31 | -1.11% |
